<DOC>
	<DOCNO>NCT00655356</DOCNO>
	<brief_summary>The purpose study evaluate safety profile treatment effect Isolagen TherapyTM compare placebo administer bilateral nasolabial fold wrinkle .</brief_summary>
	<brief_title>Safety Efficacy Study Isolagen Therapy Treatment Nasolabial Fold Wrinkles</brief_title>
	<detailed_description />
	<criteria>Subject least 18 year age Level severity bilateral nasolabial fold wrinkle meet severity criterion per protocol Level subject dissatisfaction nasolabial fold wrinkle per protocol Ability comply study requirement Negative pregnancy test ( Females ) Healthy postauricular skin biopsy Excessive dermatochalasis treatment area Inability lessen nasolabial fold wrinkle physically spread area apart Total area treat exceeds 20 cm length Physical attribute may prevent assessment treatment judge evaluator Use investigational product/procedure within 30 day prior enrollment plan use study Previous treatment sponsor 's product History active autoimmune disease organ transplantation Diagnosis cancer , unless successfully treat remission ( basal cell carcinoma exclude ) Active chronic skin disease Known genetic disorder affect fibroblast collagen Active systemic infection Requires chronic antibiotic steroidal therapy Use certain commercial products/procedures treatment area prior study enrollment plan use study Use systemic agent increase bleed clot , disorder equate effect Known allergic reaction agent used preparation treatment Excessive exposure sun without adequate sun protection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Treatment moderate severe bilateral nasolabial fold wrinkle</keyword>
</DOC>